Seroprevalance of ToRCH Infection –A Laboratory Profile

Anup Poudyal, Nimesh Poudyal, Basudha Khanal

Abstract


Background: ToRCH infection (Toxoplasma gondii, Rubella virus, Cytomegalovirus, Herpes simplex virus) causes severe consequences in child in ongoing pregnancy. Screening for ToRCH etiologies are sought for those females who have had bad obstetrics history and in children born with birth defects. Such screening helps the couple and the clinicians to develop a consensus for preparedness of adverse fetal outcome, future prevention and planning for next conception.

Objectives: This retrospective study was conducted to have an understanding on the burden of ToRCH infection in various clinically suspected cases encountered in BPKIHS.

Methods:  Laboratory record of 52 serum samples submitted from August 2012 to July 2013 for screening of ToRCH infections was analyzed.

Result: Among 52 adult female serums, most (50) were positive for Cytomegalovirus (CMV) IgG, but none were reactive for Rubella IgM. Both IgG and IgM were positive for CMV in 10 cases, Herpes Simplex Virus (HSV) in 1 case and Toxoplasma in 1 case.

Conclusion: This study shows, CMV as the most common and Toxoplasma as the least common etiology among the ToRCH profile, in our setup.


Keywords


IgG, IgM, Pregnancy

Full Text:

PDF

References


Stegmann BJ, Carey JC. TORCH infections Toxoplasmosis, other (syphilis, varicella-zoster, parvovirus B19), Rubella, cytomegalovirus (CMV), and herpes infections. Curr Women Health Rep.2002;2(4):253–8.

Maruyama Y, Sameshima H, Kamitomo M, et al. Fetal manifestations and poor outcomes of congenital cytomegalovirus infections: possible candidates for intrauterine antiviral treatments. J Obstet Gynaecol. 2007;33(5):619–23.

WHO. Toxoplasmosis- Fact Sheet, 2015

La de L Galvan Ramirez M, Mancilla S, Castrejon OV, et al. Incidence of anti-toxoplasma antibodies in women with high risk pregnancy and habitual abortion. Rev Soc Bras Med Trop.1995;28(4):333–7.

Chopra Shashi, Arora Usha, Aggarwal Aruna. Prevalence of IgM antibodies to toxoplasma, rubella and cytomegalovirus infections during pregnancy. JK Sci. 2004;6(4):190–2.

Rai SK, Shibata H, Sumi K et al. Toxoplasma antibody prevalence in Neplese pregnant women and women with bad obstetric history. Southeast Asian J Trop Med Public Health. 1998;29(4):739-43

Lee JY, Bowden DS. Rubella virus replication and links to teratogenicity. Clin Microbiol Rev. 2000;13:571–87.

Gandhoke I, Aggarwal R, Lal S, et al. Seroprevalence and incidence of rubella in and around Delhi (1988-2002). Indian J Med Microbiol. 2005;23(3):164–7.

WHO-SEARO, Nepal. EPI –Fact Sheet, 2016.

Fowler KB, Pass RF. Risk factors for congenital cytomegalovirus infection in the offspring of young women: exposure to young children and recent onset of sexual activity. Pediatrics. 2006;118:e286–92.

Al-Hareth Z, Monem F, Abdel Megiud N. Is low birth weight a risk indicator for congenital cytomegalovirus infection? J. Infect Dev Ctries. 2010;4:044–7.

Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17:355–63.

Landolfoa S, Garigliob M, Gribaudoa G, et al. The human cytomegalovirus. Pharmacol Ther. 2003;98(3):269–97.

Gandhoke I, Aggarwal R, Lal S, et al. Congenital CMV infection in symptomatic infants in Delhi and surrounding areas. Indian J Pediatr. 2006;73:1095–7.

Yasodhara P, Ramalakshmi BA, Naidu AN, et al. Prevalence of specific IgM due to Toxoplasma, Rubella, CMV and C Trachomatis infections during pregnancy. Indian J Med Microbiol. 2001;19(2):79–82.

Sen MR, Shukla BN, Tuhina B. Prevalence of serum antibodies to TORCH infection in and around Varanasi, Northern India. J Clin Diagn Res. 2012;6(9):1483–5.

Aacharya D, Shrestha S, Bogati B et al. Immune status in infection by cytomegalovirus in women with bad obstetric history. Int J Infect Microbiol 2013;2(1):3-6.

Anzivino Elena, Fioriti Daniela, Mischitelli Monica, et al. Herpes simplex virus infection in pregnancy and in neonate: status of art of epidemiology, diagnosis, therapy and prevention. Virol J. 2009;6:40.

Cusini Marco, Ghislanzoni Massimo. The importance of diagnosing genital herpes. J Antimicrob Chemother. 2001;47:9–16.

Ural HSerdar genital herpes in pregnancy. [http://emedicine. medscape.com/article/274874-overview], Accessed 18 February 2018.

Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. New Engl J Med. 1997; 337(8):509–15.

Biswas D, Borkakoty B, Mahanta J, et al. Seroprevalence and risk factors of herpes simplex virus type-2 infection among pregnant women in Northeast India. BMC Infect Dis. 2011;11:325.

Haider M, Rizvi M, Khan N, et al. Serological study of herpes virus infection in female patients with bad obstetric history. Biol Med. 2011;3(2):284–90.

Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis.2002;186:S3–28.

Kubo T1, Rai SK, Nakanishi M, Yamano T. Seroepidemiological study of herpes viruses in Nepal. Southeast Asian J Trop Med Public Health. 1991 Sep;22(3):323-5.

WHO. Congenital anomalies-Fact sheet. Updated September 2016.




DOI: https://doi.org/10.7439/ijbr.v9i4.4734

Refbacks

  • There are currently no refbacks.




Copyright (c) 2018 International Journal of Biomedical Research

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.